Beta Bionics Inc. (BBNX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
22.26
1.77 (8.64%)
At close: Oct 03, 2025, 3:59 PM
22.26
0.00%
After-hours: Oct 03, 2025, 04:35 PM EDT

Beta Bionics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-73.37M -70.96M -54.76M -55.5M -54.44M -39.98M -27.53M -8.68M
Depreciation & Amortization
1.79M 1.71M 1.67M 1.68M 1.68M 1.11M 544K n/a
Stock-Based Compensation
11.13M 6.33M 4.88M 4.91M 4.2M 4.2M 2.84M 1.27M
Other Working Capital
-1.12M -330K 5.39M 4.59M 3.97M 1.18M 2.15M n/a
Other Non-Cash Items
15.54M 20.56M 12.08M 18.03M 25.96M 21.63M 18.36M 7.41M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-12.55M -13.74M -12.15M -9.47M -8.13M -5.45M -566K n/a
Operating Cash Flow
-57.46M -56.1M -48.27M -40.34M -30.73M -18.49M -6.35M n/a
Capital Expenditures
-4.59M -3.32M -3.4M -3.15M -1.23M -719K -313K n/a
Cash Acquisitions
n/a n/a 50K 50K 50K 50K n/a n/a
Purchase of Investments
-273.77M -278.92M -72.13M -96.33M -89.49M -69.3M -69.3M n/a
Sales Maturities Of Investments
91M 92M 72M 56M 32M 8M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-187.37M -190.24M -3.48M -43.42M -58.66M -61.96M -69.61M n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
217K 98K n/a n/a -119K n/a n/a n/a
Financial Cash Flow
266.88M 266.73M 55.62M -1.27M -92K 15K 9K n/a
Net Cash Flow
35.08M 33.41M 16.89M 30.61M 13.13M 22.17M 26.67M n/a
Free Cash Flow
-62.05M -59.43M -51.67M -43.49M -31.95M -19.21M -6.66M n/a